Intravenous busulfan-based conditioning with autologous stem cell transplantation for refractory B-cell lymphoma with central nervous system involvement-Reference-Cited by-同舟云学术

Intravenous busulfan-based conditioning with autologous stem cell transplantation for refractory B-cell lymphoma with central nervous system involvement

Published:2021 Issue:1.2 Volume:68 Page:196-201
ISSN:1343-1420
Container-title:The Journal of Medical Investigation
language:en
Short-container-title:J. Med. Invest.

Author:

Takahashi Mamiko¹,Sumitani Ryohei¹,Hori Taiki¹,Murai Jumpei¹,Kawata Shiyori¹,Oura Masahiro¹,Sogabe Kimiko¹,Harada Takeshi¹,Fujii Shiro¹,Miki Hirokazu²,Kagawa Kumiko¹,Abe Masahiro¹,Nakamura Shingen³

Affiliation:

1. Department of Hematology, Endocrinology and Metabolism, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan

2. Division of Transfusion Medicine and Cell Therapy, Tokushima University Hospital, Tokushima, Japan

3. Department of Community Medicine and Medical Science, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan

Publisher

University of Tokushima Faculty of Medicine

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

https://www.jstage.jst.go.jp/article/jmi/68/1.2/68_196/_pdf

Reference29 articles.

1. 1. Boehme V, Zeynalova S, Kloess M, Loeffler M, Kaiser U, Pfreundschuh M, Schmitz N : Incidence and risk factors of central nervous system recurrence in aggressive lymphoma--a survey of 1693 patients treated in protocols of the German High-Grade Non-Hodgkin’s Lymphoma Study Group (DSHNHL). Ann Oncol 18(1) : 149-157, 2007

2. 2. Zinzani PL, Magagnoli M, Frezza G, Prologo G, Gherlinzoni F, Bendandi M, Albertini P, Babini L, D’Alessandro R, Tura S : Isolated central nervous system relapse in aggressive non-Hodgkin’s lymphoma : the Bologna experience. Leuk Lymphoma 32(5-6) : 571-576, 1999

3. 3. Graham MS, DeAngelis LM : Improving outcomes in primary CNS lymphoma. Best practice & research Clinical haematology 31(3) : 262-269, 2018

4. 4. Strong JM, Collins JM, Lester C, Poplack DG : Pharmacokinetics of intraventricular and intravenous N,N’,N’’-triethylenethiophosphoramide (thiotepa) in rhesus monkeys and humans. Cancer Res 46(12 Pt 1) : 6101-6104, 1986

5. 5. Hassan M, Ehrsson H, Smedmyr B, Totterman T, Wallin I, Oberg G, Simonsson B : Cerebrospinal fluid and plasma concentrations of busulfan during high-dose therapy. Bone Marrow Transplant 4(1) : 113-114, 1989